Proofpoint, Inc. (PFPT) stock prices updated...
 

Proofpoint, Inc. stock price

Proofpoint, Inc. latest news:


  • 02/06/2018 14:55:07

    Proofpoint agrees to buy Wombat Security Technologies for $225 million

    Proofpoint Inc. said late Tuesday it had agreed buy Wombat Security Technologies Inc. for $225 million in cash. The deal is expected to close in the first quarter, the company said. The acquisition gives Proofpoint a foothold in the phishing simulation and security awareness training market. "The acquisition of Wombat gives us greater ability to help protect our customers from today's people-centric cyberattacks, as cybercriminals look for new ways to exploit the human factor," Proofpoint said in a statement. The company said it expects the deal to increase its 2018 revenue by $30 million to $32 million, and billings by $30 million to $32 million. Also Tuesday, Proofpoint reported an adjusted profit of 29 cents a share on sales of $145.4 million in the fourth quarter. That compares with adjusted earnings of 18 cents a share on sales of $106.8 million in the year-ago period. Analysts polled by FactSet had expected adjusted earnings of 20 cents a share on sales of $139.6 million. Proofpoint shares were flat in the extended session after ending the regular trading day up 3.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/06/2018 14:19:36

    BRIEF-Proofpoint To Acquire Wombat Security Technologies For $225 Mln In Cash

    Proofpoint Inc(PFPT): * PROOFPOINT ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE WOMBAT SECURITY TECHNOLOGIES FOR $225 MILLION IN CASH; MOVES INTO PHISHING SIMULATION AND SECURITY AWARENESS TRAINING MARKET. * Proofpoint Inc(PFPT) - EXPECTS WOMBAT TO INCREASE 2018 REVENUE RANGE BY $30 MILLION - $32 MILLION. * Proofpoint Inc (PFPT) - EXPECTS WOMBAT TO INCREASE 2018 BILLINGS RANGE BY $30 MILLION - $32 MILLION.

  • More trends:

    ProPhase Labs, Inc.PRPH | ProQR Therapeutics N.V.PRQR | ProShares Ultra search BiotechnologyBIB | Proshares UltraPro search BiotechnologyUBIO | ProShares UltraPro QQQTQQQ | ProShares UltraPro Short search BiotechnologyZBIO | ProShares UltraPro Short QQQSQQQ | ProShares UltraShort search BiotechnologyBIS | Prospect Capital CorporationPSEC | Proteon Therapeutics, Inc.PRTO |